Furth et al (1991) "Inhibition of HIV Protease with Non-Peptide Derivatives of Haloperidol", Fourth Chemical Congress of north America, NY, NY, USA, Aug. 25-30, 1991, Abstr. |
De Camp et al, "Structure-Based Inhibition of HIV-1 Protease Activity And Viral Infectivity", in Structure and Function of the Aspartic Proteinases, Dunn, ed., published 1991 by Plenum Press, pp. 489-492. |
L. Ratner, et al. "Complete nucleotide sequence of the AIDS virus, HTLV-III," Nature 323:277-284 (1985). |
T. J. McQuade, et al. "A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle Maturation," Science 247:454-457 (1990). |
H. P. Schnebli and N. J. Braun, "Proteinase inhibitors as drugs," (1986) Elsevier Science Publishers BV. |
J. J. Blumenstein, et al. "Synthetic Non-Peptide Inhibitors of HIV Protease," Biochem. and Biophys. Res. Comm. 163:980-987 (1989). |
K. Moelling, et al. "In vitro inhibition of HIV-1 proteinase by cerulenin," FEBS Letters 261:373-377 (1990). |
N. A. Roberts, et al. "Rational Design of Peptide-Based HIV Proteinase Inhibitors," Science 248:358-361 (1990). |
R. Pal, et al. "Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulein," Proc. Natl. Acad. Sci. 85:9283-9286 (1988). |
W. G. Farmerie, et al. "Expression and Processing of the AIDS Virus Reverse Transcriptase in Escherichia coli," Science 236:305-308 (1987). |
C. Debouck, et al. "Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor," Proc. Natl. Acad. Sci. 84:8903-8906 (1987). |
N. E. Kohl, et al. "Active human immunodeficiency virus protease is required for viral infectivity," Proc. Natl. Acad. Sci. 85:4686-4690 (1988). |
M. A. Navia, et al. "Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1," Nature 337:615-620 (1989). |
R. Lapatto, et al. "X-ray analysis of HIV-1 proteinase at 2.7 .ANG. resolution confirms structural homology among retroviral enzymes," Nature 342:299-302 (1989). |
A. Wlodawer, et al. "Conserved Folding in Retroviral Proteases: Crystal Structure of a Synthetic HIV-1 Protease," Science 245:616-621 (1989). |
S. Seelmeier, et al. "Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A," Proc. Natl. Acad. Sci. 85:6612-6616 (1988). |
P. L. Darke, et al. "Human Immunodeficiency Virus Protease," J. Bio. Chem. 264:2307-2312 (1989). |
T. D. Meek, et al. "Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease," Proc. Natl. Acad. Sci. 86:1841-1845 (1989). |
L. H. Pearl and W. R. Taylor, "A structural model for the retroviral proteases," Nature 329:351-354 (1987). |
A. G. Tomasselli, et al. "Substrate Analogue Inhibition and Active Site Titration of Purified Recombinant HIV-1 Protease," Biochemistry 29:264-269 (1990). |
T. D. Meek, et al. "Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues," Nature 343:90-92 (1990). |
S. Pichuantes, et al. "Recombinant HIV2 Protease Processes HIV1 Pr53.sup.gag and Analogous Junction Peptides in Vitro," J. Bio. Chem. 265:13890-13898 (1990). |
R. L. DesJarlais, et al. "Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease," Proc. Natl. Acad. Sci 87:6644-6648 (1990). |
M. L. Moore, et al. "Peptide Substrates and Inhibitors of the HIV-1 Protease," Biochem. and Biophys. Res. Comm. 159:420-425 (1989). |
T. Maniatis, et al. "Molecular Cloning, A Laboratory Manual," (Cold Spring Harbor Press NY (1982). |
L. Babe' et al., "HIV1 Protease: Bacterial Expression, Purification and Characterization," Protein and Pharm. Eng. pp. 71-88 (1990). |
G. B. Dreyer, et al., "Inhibition of human immunodeficiency virus 1 protease in vitro: Rational design of substrate analogue inhibitors," Proc. Natl. Acad. Sci. USA vol. 86 pp. 9752-9756 (Dec. 1989). |
H. Toh, et al., "Close structural resemblance between putative polymerase of a Drosophila transposable genetic element 17.6 and pol gene product of Moloney murine leukaemia virus" EMBO J. vol. 4 5:1267-1272 (1985). |
M. D. Power, et al., "Nucleotide Sequence of SRV-1, a Type D Simian Acquired Immune Deficiency Syndrome Retrovirus," Science 231:1567-1572 (Mar. 1986). |
AIDS Research and Reference Reagent Program Catalog (Jan. 1991 Catalog) NIH Pub. No. 91-1536. |